反応式
[CH3:1][N:2]1[CH2:7][CH2:6][N:5]([C:8]2[CH:14]=[CH:13][C:11]([NH2:12])=[CH:10][CH:9]=2)[CH2:4][CH2:3]1.[C:15]1([C:25]2[C:34]3[N:33]=[CH:32][CH:31]=[N:30][C:29]=3[C:28]([C:35](O)=[O:36])=[CH:27][CH:26]=2)[C:24]2[C:19](=[CH:20][CH:21]=[CH:22][CH:23]=2)[CH:18]=[CH:17][CH:16]=1.C1(B(O)O)C2C(=CC=CC=2)C=CC=1>C(Cl)Cl.CO>[CH3:1][N:2]1[CH2:3][CH2:4][N:5]([C:8]2[CH:14]=[CH:13][C:11]([NH:12][C:35]([C:28]3[C:29]4[N:30]=[CH:31][CH:32]=[N:33][C:34]=4[C:25]([C:15]4[C:24]5[C:19](=[CH:20][CH:21]=[CH:22][CH:23]=5)[CH:18]=[CH:17][CH:16]=4)=[CH:26][CH:27]=3)=[O:36])=[CH:10][CH:9]=2)[CH2:6][CH2:7]1参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
The title compound was prepared in analogy to the procedure described in in Step 14.1 but stirring the reaction mixture overnight and using 4-(4-methylpiperazin-1-yl)-aniline (WO2006000420) and 8-naphthalen-1-yl-quinoxaline-5-carboxylic acid. The latter compound was synthesized as described in Steps 1.2-1.7 but using 1-naphtylboronic acid in Step 1.4. Title compound: ESI-MS: 474.0 [M+H]+; tR=4.34 min (System 1); TLC: Rf=0.45 (DCM/MeOH/NH3aq, 94:5:1).
後処理
- customThe title compound was prepared in analogy to the procedure
- customThe latter compound was synthesized
出典と根拠
- ORDレコード
- ord-cb48339784fb41b5b6cdbf7ed92c34d3
- 出典データセット
- uspto-grants-2013_09
- 特許番号
- US08536175B2
関連ノート
読み込み中…